Literature DB >> 16583173

Prevalence of suspected diastolic dysfunction in patients with a clinical diagnosis of congestive heart failure.

Mohammad-Reza Movahed1, Mastaneh Ahmadi-Kashani, Yuji Saito.   

Abstract

INTRODUCTION: The prevalence of diastolic left ventricular (LV) dysfunction in a population presenting with a suspected diagnosis of congestive heart failure (CHF) is questionable and widely variable in the current literature. To minimize the disparity, we evaluated a large echocardiographic database to investigate the prevalence of systolic and suspected diastolic LV dysfunction in those with a suspected clinical diagnosis of CHF.
METHODS: We retrospectively reviewed echocardiograms performed at our institution and evaluated the prevalence of abnormal LV systolic and diastolic function in those with a suspected clinical diagnosis of CHF. Diastolic dysfunction was defined as the presence of left atrial enlargement, left ventricular hypertrophy and reverse trans-mitral inflow ratio (E/A reversal).
RESULTS: Of the 636 echocardiograms with CHF as the primary diagnosis, 461 had measured LV function. Normal LV systolic function were found in 238 of the patients (48%). Isolated diastolic LV dysfunction was found in 166 patients (36%). Twelve percent of the patients with a suspected clinical diagnosis of CHF had normal LV systolic and diastolic function.
CONCLUSION: Normal LV systolic function was seen in nearly one-half of the echocardiograms with a suspected clinical diagnosis of CHF. Suspected LV diastolic dysfunction was observed in one-third of the echocardiograms with a suspected clinical diagnosis of CHF.

Entities:  

Mesh:

Year:  2005        PMID: 16583173     DOI: 10.1007/s10741-005-7539-z

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  14 in total

Review 1.  Approach to patients with heart failure and normal ejection fraction.

Authors:  A A Elesber; M M Redfield
Journal:  Mayo Clin Proc       Date:  2001-10       Impact factor: 7.616

Review 2.  Clinical practice. Diastolic heart failure.

Authors:  Gerard P Aurigemma; William H Gaasch
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

3.  Diastolic heart failure: neglected or misdiagnosed?

Authors:  Prithwish Banerjee; Tumpa Banerjee; Aleem Khand; Andrew L Clark; John G F Cleland
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

Review 4.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment.

Authors:  Michael R Zile; Dirk L Brutsaert
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

5.  Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

Authors:  R S Vasan; M G Larson; E J Benjamin; J C Evans; C K Reiss; D Levy
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

Review 6.  Heart failure with preserved systolic function. A different natural history?

Authors:  M Senni; M M Redfield
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

Review 7.  Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective.

Authors:  R S Vasan; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1995-12       Impact factor: 24.094

8.  Gender, age, and heart failure with preserved left ventricular systolic function.

Authors:  Frederick A Masoudi; Edward P Havranek; Grace Smith; Ronald H Fish; John F Steiner; Diana L Ordin; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2003-01-15       Impact factor: 24.094

Review 9.  Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction.

Authors:  W H Gaasch
Journal:  JAMA       Date:  1994-04-27       Impact factor: 56.272

Review 10.  Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.

Authors:  Karen Hogg; Karl Swedberg; John McMurray
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.